Increased systemic levels of TNF-α in T2DM increases the inflammatory pathways in muscles, particularly the NFκB pathway, which was reported to contribute to T2DM-mediated muscle atrophy [85]. This evidence concerns the gene TNF and type 2 diabetes mellitus.